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A B S T R A C T
Purpose: The optimal therapy of patients with cerebral cavernoma (CCs) and new onset epilepsy,
sporadic seizures, or non well established refractory epilepsy is still not clear. The aim of this study was
to compare the incidence of seizures in patients with CCs both operated and non operated, in order to
obtain more information on the correct management of these patients.
Materials andmethods: We studied retrospectively 43 patientswith non refractory epilepsy secondary to
CCs. Twenty-six of them (60.5%) underwent surgery and made up the surgical group, and 17 patients
were treatedmedically and constituted themedical group. Seizure frequency and other clinical variables
were compared between both groups.
Results: At two years, out of the 26 operated patients, 19 (73%) remained seizure free, 4 (15%) had less
than a seizure per month, and one patient (4%) had more than one seizure per month. At ﬁve years, 15
patients of the surgical group remained for analysis. Of them, 11 (73.3%) were seizure free, and 4 (26.7%)
had less than one seizure a month. In the medical group, 12 out of 17 patients were seizure free (70.6%).
There were no signiﬁcant differences between the two groups (p = 0.2 and p = 0.3, respectively). Seven
patients had postoperative neurological sequelae.
Conclusion: Surgical treatment of patients with non refractory epilepsy due to CCs did not signiﬁcantly
reduce the likelihood of seizures when compared to medical treatment. It must also be considered that
surgery carries serious risks. A prospective and randomized study must be carried out to further clarify
our ﬁndings.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Cerebral cavernous malformations are hamartomous vascular
lesions of the brain with an approximated prevalence of 0.2–0.9% –
shown by necropsy and/or magnetic resonance imaging (MRI)
studies.1,2 They constitute nearly 10% of all vascular cerebral
malformations.3 The annual bleeding rate has been estimated to
be between 0.2% and 3% per person per year of exposure.2,4–7
Seizures are the most common clinical presentations in supraten-
torial cavernomas. Seizures are probably provoked because caver-
nomas have a tendency to microhemorrhage into adjacent brain
tissueresulting insurroundinghemosiderinandgliosis, predisposing
to epileptogenicity.8 The literature documents several studies ofAbbreviation: ILAE, International League Against Epilepsy.
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1059-1311/$ – see front matter  2012 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2012.09.004patients with well established refractory epilepsy secondary to
cerebral cavernomas where surgery of the cerebral lesions resulted
in high rates of seizure freedom.9–12 However, there are no
prospective randomized studies comparing surgical and conserva-
tive treatments for this typeofpatient.Therefore, it is still unknownif
resection of the lesion is the optimal treatment for patients with
cavernomas and new onset epilepsy, sporadic seizures, or non well
established refractory epilepsy. Theaimof this studywas tocompare
clinical evolution in terms of seizure frequency of patients with
cerebral cavernomas operated and non operated in order to obtain
more information to the optimal management of these patients.
2. Materials and methods
2.1. Patients
We initially recruited retrospectively 54 patients with
cerebral cavernomas and epilepsy from our clinical database.vier Ltd. All rights reserved.
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seizure (before surgery in patients operated); (b) presence of
supratentorial cavernoma, single or multiple, determined by
computed tomography (CT) or MRI; and (c) at least, one year of
follow up. All patients underwent a CT or MRI scan. Exclusion
criteria were the presence of well established refractory
epilepsy, deﬁned by the recent proposal of ILAE for refractory
epilepsy as failure of two adequate and well tolerated
treatments in mono or bitherapy13 before surgery. After being
diagnosed of cavernoma, most patients were ﬁrst sent to a
neurosurgical service, so surgery was in most cases indicated by
a neurosurgeon. Then, a lesionectomy or an extended lesio-
nectomy was performed if the cavernoma was located in a non
eloquent region. Surgery was undertaken on 19 patients because
of seizures and 7 because of hemorrhages. None of the patients
studied had a complete presurgical epilepsy evaluation. Only
one patient was monitored through cortical mapping during
surgery.
There were a number of reasons why some patients were only
given medical treatment: because of the excellent control of their
epilepsy, the location of the cavernoma in an eloquent area or
because the patient declined surgery.
Patients were divided into two groups: (a) the surgical group –
these were the patients that underwent surgery and were treated
by lesionectomy or extended lesionectomy and (b) the medically
treated group.
2.2. Methods
A variety of clinical variables were analyzed, such as age and
gender, age at epilepsy onset, duration of epilepsy, age at
operation, kind and frequency of seizures, localization and size
of cavernoma, presence of hemosiderin surrounding the caver-
noma before and after surgery. The primary endpoint was the
seizure frequency of the operated and non operated patients. We
also looked at the possibility of treatment withdrawal, and
the presence of surgical sequelae, and cavernoma bleeding during
the follow up.Table 1
Comparison of the principal clinical features between the surgical and the conservati
Abbreviations: GTCS: generalized tonic-clonic seizures; CPS: complex partial seizures;
Surgical gr
Age, mean 44,8 (rang
Gender 16 men (6
10 women
Localization of cavernoma Temporal
Frontal 9 (
Parietal 6
Occipital 0
Multiple 4
Size of cavernoma (cm) <2 cm 11
2–6cm 15
Type of seizures GTCSCPS
CPS 6 (24%
SPS 10 (38
Age at onset 36,5 (rang
Hemosiderin on presurgical MRI 20 (77%)
Indication of sugery 19/26 (73%
7/26 (27%)
Seizure frequency pre surgery Isolated se
3 seizure
Annual sei
1 month
Epilepsy duration (pre surgery) 40 months
Neurological deﬁcit 2 (8%)2.3. Statistics
Statistical analysis was undertakenwith SPSS 12.0 forWindows
(SPSS Inc., Chicago, IL, USA), and comparisons were performed
using the Mann–Whitney U test.
3. Results
3.1. Demographic and clinical data
Out of the 54 patients recruited from our database, 11 were
excluded from the analysis because of the presence of refractory
epilepsy. Thus, the study was composed of 43 patients, aged
between 23 and 74 years (mean, 47 years). Twenty-six patients
(60.5%) were men, and 17 (39.5%), women. Mean age of seizure
onset was 36 years (range 9–70 years). Localizations of the
cavernomas in the brain were: 13 frontal, 13 temporal, 8 parietal, 8
multiple, and one patient had an occipital localization. The
cavernoma was sized less than 2 cm in 19 patients (44.2%),
between 2 and 6 cm in 23 (53.5%), and greater than 6 cm in one
patient (2.3%). Hemosiderin deposits surrounding the cavernous
angioma were detected by MRI in 30 cases (69.8%). Finally, 26
patients (60.5%) underwent surgery (lesionectomy in 22, and
extended lesionectomy in 4). These 26 patients composed the
surgical group, and the 17 non operated patients composed the
medical conservative group. Comparison of principal demographic
and clinical data of both groups is summarized in Table 1. There
were no signiﬁcant differences in the baseline clinical character-
istics between both groups.
3.2. Seizure outcome
At two years, 19 out of the 26 operated patients (73%) remained
free of seizures, 4 (15%) had a seizure frequency lower than a
seizure per month, and only one patient (4%) had more than one
seizure per month. At ﬁve years, 15 patients of the surgical group
remained for analysis. Of them, 11 (73.3%) were free of seizures,
and the other 4 patients (26.7%) had less than one seizure a month.ve treatment groups. There were not signiﬁcant differences between two groups.
SPS: simple partial seizures.
oup (n=26) Medical group (n=17)
e 23–65) 50,2 (range 7–74)
1%)
(39%)
10 men (59%)
7 women (41%)
7 (27%)
34%)
(23%)
(0%)
(15%)
Temporal 6 (35%)
Frontal 4 (23%)
Parietal 2 (12%)
Occipital 1 (6%)
Multiple 4 (23%)
(42%)
(58%)
<2cm 8 (47%)
2–6 cm 8 (47%)
>6cm 1 (6%)
-SPS 10 (38%)
)
%)
GTCSCPS-SPS 8 (47%)
CPS 5 (30%)
SPS 4 (23%)
e 9–63) 38,8 (range 13–70)
10 (59%)
): seizures
hemorraghe
–
izure 8 (31%) –
s 10 (38%)
zure: 3 (11%)
ly: 5 (20%)
(range 0–376) –
0
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free (70.6%). Only three patients of this group had a follow up less
than 3 years. There were no signiﬁcant differences in the incidence
of seizures between the two groups (p = 0.2 and p = 0.3,
respectively). Eleven patients of the surgical group were lost in
the follow up because they were sent to their original hospitals. In
seven patients surgery produced some neurological sequelae:
dysesthesia, facial weakness, homonym hemianopsia, hemipar-
esis, mild dysphasia, and depression. Three out of the 4 patients
who underwent extended lesionectomy (75%)were free of seizures
at 2 and 5 years. Among the patients that underwent pure
lesionectomy, 22 (72%) and 10 (66%) were free of seizures at 2 and
5 years follow up, respectively. In this group, antiepileptic drugs
could be withdrawn from 9 of the 26 patients (34.6%) at two years,
and from 5 of the 15 patients at ﬁve years (32.3%).
In the surgical group, seizure outcome was related neither to
the occurrence of generalized tonic clonic seizures nor the number
of seizures before surgery. However, patients who had epilepsy
less than 18months prior to surgery had a better outcome at 2 and
at 5 years than the patients whose epilepsy was longer than 18
months previous to surgery: 15 of 16 patients (93%) at 2 years and
9 of 10 patients (90%) at 5 years were free of seizures while 5 of –
(50%) at 2 years and 2 of 5 (40%) at 5 years were free of seizures.
These were not statistically signiﬁcantly different.
In the medical treatment group, 12 of the 17 patients remained
seizure free (70.6%), one patient (5.9%) had an annual seizure, 3
(17.6%) had a seizure frequency less than one per month, and one
patient (5.9%) had 2 or more seizures per month. Antiepileptic
drugswerewithdrawn from 3 patients (14, 2%) due to good control
of seizures and pregnancy desire.
Comparing both groups, there were no signiﬁcant differences in
terms of seizure outcome either at 2 and 5 years (p = 0.2 and
p = 0.3, respectively).
No patients in themedical group had neurological deterioration
during the follow up.We did not observeworsening of the seizures
in this group, but no patient had sequential MRI during the follow
up.
3.3. Multiple cavernomatosis
Eight patients had multiples cavernomas. Four patients
underwent surgery because of hemorrhage: three of them became
seizure free (75%), and the other continues to have seizures with an
annual frequency. The four patients who did not undergo surgery
were seizure free.
4. Discussion
In our study, the outcome of patients – in terms of seizure
frequency – did not show signiﬁcant differences between the
patients that underwent surgery, and those whowere treated with
conservative medical treatment (p = 0.2 and p = 0.3, respectively).
We found similar results in patients with multiple cavernomas.
However, the operated patients had more probability of successful
withdrawal of antiepileptic treatment than the patients of the
medically treated group (32–34% vs. 14%, respectively). Our results
show (with some limitations listed below) that surgery in patients
with new onset epilepsy, sporadic seizures, or nonwell established
refractory epilepsy should be planned with caution, because
seizure frequency would probably be the same had the patient
received medical treatment instead.
Cavernomas are increasingly recognized as a cause of epilep-
sy,14 and can produce refractory epilepsy. It is important to know
precisely which is the best approximation to treat these patients. A
detailed review of the literature on this issue reveals that surgery
reaches high rates of seizure freedom in patients with cavernomas.In most cases, seizure freedom is higher than 70%.19,10,12,15–21 The
principal predictors of complete seizure freedom were: total
resection of cavernomas,11 short history of epilepsy,11,12,17–20 low
number of seizures prior to surgery,12,19,20 temporal localization of
cavernoma,9 absence of generalized tonic clonic seizures,9,10 and
small size of cavernoma.9,10 A recent review of the articles
published in the past 25 years found the following characteristics
correlated with favorable outcomes: extent of resection of the
cavernoma and its surrounding hemosiderin ring, sporadic or
single seizures, duration of epilepsy lesser than 1–2 years, and size
of the cerebral cavernoma less than 1.5 cm.22 In our study, the
unique factor that was associated with better outcomes was short
history of epilepsy, although, probably due to the low number of
patients, we did not ﬁnd signiﬁcant differences. However, this
study was not directly designed to study prognostic factors.
Based on the literature data, it seems clear that surgical
treatment is the best approach for patients with well established
refractory epilepsy. However, there are no prospective randomized
studies comparingmedical and surgical treatment in patients with
cavernomas and non refractory epilepsy. Our study, although
retrospective, provides – to our knowledge – the largest
comparative study between surgical or conservative treatment
in patients with cerebral cavernomas. We only found in the
literature a retrospective study of Noto et al.19 inwhich the authors
analyzed retrospectively 31 patients with cavernomas and
epilepsy. Fifteen patients were treated medically, and 16 under-
went surgery. The percentage of patients who became seizure free
was signiﬁcantly higher in the surgical group, so they concluded
that surgical intervention may have greater beneﬁts that medical
treatment for these patients. Our study shows the same successful
results of surgery, but we found a higher rate of seizure control in
the medical group. However, we agree with Noto et al., that the
number of anticonvulsivants can be reduced more with surgery
than with medical treatment.
In both our groups, patients with multiple cavernomas had an
excellent control of seizures. Previous studies also showed high
rates of seizure control (>70%) in patients with multiple cerebral
cavernous malformations.23,24
Our study was limited by the non randomized group selection,
the retrospective nature of the analysis, and the low number of
patients, especially in the medical group, although this is, to our
knowledge, themajor series reported in the literature. In respect to
the patients treated medically, another point that has to be taken
into account is that the proper follow up of patients with epilepsy
associated with cavernous angioma requires a prolonged period of
time. Indeed, in our study, although one of the inclusion criteria
was aminimal follow up of a year, themedian age of the patients of
the medical group was 50.2 years old, and their median age at the
onset of epilepsy was 38, with only three patients in this group
having a follow up below 3.
5. Conclusion
Although, at present, the surgical approach to cavernomas
seems to better control seizures, this is not deﬁnitive. Surgery also
has potentially serious risks. We believe that management of
patients with cerebral cavernomas and epilepsy should be
conducted according to the concepts of elective Epilepsy Surgery,
with the standard epilepsy presurgical evaluation. A prospective
and randomized study also needs be undertaken to clarify this
uncertainty.
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